UPDATED May 30, 2024
Discover U.S. Healthcare Growth Stocks that are on the NYSE and NASDAQ. Sorted by forecasted growth, these Healthcare Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
LFST | US$5.57 | -2.3% | -34.2% | US$2.1b | US$8.79 | PS1.9x | E45.8% | n/a | ||
MGRM | US$2.00 | -2.0% | -59.4% | US$63.3m | US$6.00 | PS173.5x | E45.6% | n/a | ||
HCAT | US$6.51 | -3.3% | -45.8% | US$384.3m | US$11.50 | PS1.3x | E45.0% | n/a | ||
OM | US$3.54 | -8.5% | -84.1% | US$183.1m | US$5.64 | PS1.5x | E44.7% | n/a | ||
NUWE | US$0.28 | 10.8% | -90.0% | US$5.0m | n/a | PB5.6x | E44.6% | n/a | ||
GDRX | US$7.56 | 5.9% | 40.3% | US$2.8b | US$9.40 | PS3.7x | E43.0% | n/a | ||
ACHC | US$67.34 | 5.9% | -3.1% | US$6.2b | US$88.67 | PS2.1x | E42.3% | n/a | ||
NXGN | US$23.94 | 0.04% | 19.3% | US$1.6b | US$22.69 | PS2.3x | E41.8% | 0% | ||
HQY | US$79.12 | -0.2% | 33.5% | US$6.9b | US$100.00 | PE123.6x | E41.4% | n/a | ||
LIVN | US$60.83 | 2.1% | 29.8% | US$3.3b | US$69.20 | PS2.8x | E41.2% | n/a | ||
GMED | US$66.59 | 1.2% | 19.4% | US$9.0b | US$71.17 | PE135x | E40.9% | n/a | ||
PRCT | US$64.22 | -4.0% | 97.6% | US$3.3b | US$73.83 | PS21.1x | E40.8% | n/a | ||
ALHC | US$7.88 | 10.1% | 24.7% | US$1.5b | US$8.50 | PB11.5x | E40.5% | n/a | ||
XRAY | US$27.75 | 1.1% | -28.5% | US$5.8b | US$33.82 | PS1.5x | E40.1% | 2.3% | ||
CTSO | US$0.88 | -2.2% | -71.4% | US$47.8m | US$2.67 | PS1.3x | E40.1% | n/a | ||
VTAK | US$0.50 | -4.3% | -52.1% | US$3.8m | US$4.10 | PS8.7x | E40.0% | n/a | ||
SHCR | US$0.85 | 2.9% | -49.7% | US$306.4m | US$1.50 | PB0.8x | E40.0% | n/a | ||
HIMS | US$20.37 | 20.7% | 126.3% | US$4.4b | US$17.33 | PS4.6x | E39.9% | n/a | ||
BDSX | US$1.35 | -6.9% | 0% | US$195.9m | US$3.25 | PS3.6x | E38.9% | n/a | ||
ZYXI | US$9.92 | -5.7% | 7.4% | US$315.2m | US$21.00 | PE38.6x | E37.3% | n/a | ||
LHCG | US$169.81 | 0.6% | 32.1% | US$5.3b | US$170.00 | PE132.7x | E37.2% | n/a | ||
RDNT | US$58.87 | 0.6% | 93.8% | US$4.3b | US$58.33 | PE204.5x | E37.0% | n/a | ||
RSLS | US$0.25 | 33.0% | -90.1% | US$5.9m | US$1.00 | PB1.3x | E36.4% | n/a | ||
BAX | US$33.43 | -1.4% | -19.1% | US$17.0b | US$45.44 | PS1.1x | E36.3% | 3.5% |